Tonshoff B, Patry C, Fichtner A, Hocker B, Bohmig G
Pediatr Transplant. 2024; 29(1):e70008.
PMID: 39711054
PMC: 11664202.
DOI: 10.1111/petr.70008.
Farcas A, Stoica M, Maier I, Maier A, Sin A
Biomedicines. 2024; 12(8).
PMID: 39200392
PMC: 11351478.
DOI: 10.3390/biomedicines12081926.
Mannon R, Vincenti F
J Am Soc Nephrol. 2024; 35(11):1603-1606.
PMID: 39102302
PMC: 11543003.
DOI: 10.1681/ASN.0000000000000475.
Badrouchi S, Bacha M, Ahmed A, Ben Abdallah T, Abderrahim E
Sci Rep. 2023; 13(1):21273.
PMID: 38042904
PMC: 10693633.
DOI: 10.1038/s41598-023-48645-w.
Klein A, Loupy A, Stegall M, Helantera I, Kosinski L, Frey E
Transpl Int. 2023; 36:11951.
PMID: 37822449
PMC: 10563802.
DOI: 10.3389/ti.2023.11951.
Toward generalizing the use of artificial intelligence in nephrology and kidney transplantation.
Badrouchi S, Bacha M, Hedri H, Ben Abdallah T, Abderrahim E
J Nephrol. 2022; 36(4):1087-1100.
PMID: 36547773
PMC: 9773693.
DOI: 10.1007/s40620-022-01529-0.
Redefining Risk Stratification and Endpoints for Clinical Trials in Kidney Transplantation: Rationale and Methodology of Proposals Submitted to the European Medicines Agency by the European Society for Organ Transplantation.
Naesens M, Schneeberger S
Transpl Int. 2022; 35:10142.
PMID: 35992750
PMC: 9386734.
DOI: 10.3389/ti.2021.10142.
Surrogate Endpoints for Late Kidney Transplantation Failure.
Naesens M, Budde K, Hilbrands L, Oberbauer R, Bellini M, Glotz D
Transpl Int. 2022; 35:10136.
PMID: 35669974
PMC: 9163814.
DOI: 10.3389/ti.2022.10136.
Poor Outcomes in Patients With Transplant Glomerulopathy Independent of Banff Categorization or Therapeutic Interventions.
Wu K, Schmidt D, Del Moral C, Osmanodja B, Lachmann N, Halleck F
Front Med (Lausanne). 2022; 9:889648.
PMID: 35646957
PMC: 9133540.
DOI: 10.3389/fmed.2022.889648.
Demonstrating Benefit-Risk Profiles of Novel Therapeutic Strategies in Kidney Transplantation: Opportunities and Challenges of Real-World Evidence.
Helantera I, Snyder J, Asberg A, Cruzado J, Bell S, Legendre C
Transpl Int. 2022; 35:10329.
PMID: 35592446
PMC: 9110654.
DOI: 10.3389/ti.2022.10329.
Shifting Clinical Trial Endpoints in Kidney Transplantation: The Rise of Composite Endpoints and Machine Learning to Refine Prognostication.
Anwar I, Srinivas T, Gao Q, Knechtle S
Transplantation. 2022; 106(8):1558-1564.
PMID: 35323161
PMC: 10900533.
DOI: 10.1097/TP.0000000000004107.
Comparison of All-Cause Mortality Between Canadian Kidney Transplant Recipients and Patients With Cancer: A Population-Based Cohort Study.
Naylor K, Kim S, McArthur E, Garg A, Vinegar M, McCallum M
Can J Kidney Health Dis. 2021; 8:20543581211056234.
PMID: 34777844
PMC: 8586164.
DOI: 10.1177/20543581211056234.
Clinical significance of tacrolimus intra-patient variability on kidney transplant outcomes according to pre-transplant immunological risk.
Kim E, Kim S, Huh K, Kim B, Kim M, Kim S
Sci Rep. 2021; 11(1):12114.
PMID: 34108576
PMC: 8190283.
DOI: 10.1038/s41598-021-91630-4.
Genetic Engineering in Combination with Semi-Synthesis Leads to a New Route for Gram-Scale Production of the Immunosuppressive Natural Product Brasilicardin A.
Botas A, Eitel M, Schwarz P, Buchmann A, Costales P, Nunez L
Angew Chem Int Ed Engl. 2021; 60(24):13536-13541.
PMID: 33768597
PMC: 8251711.
DOI: 10.1002/anie.202015852.
Humanized Mouse as a Tool to Predict Immunotoxicity of Human Biologics.
Yong K, Her Z, Tan S, Tan W, Liu M, Lai F
Front Immunol. 2020; 11:553362.
PMID: 33193321
PMC: 7604536.
DOI: 10.3389/fimmu.2020.553362.
A noninferiority design for a delayed calcineurin inhibitor substitution trial in kidney transplantation.
Nickerson P, Balshaw R, Wiebe C, Ho J, Gibson I, Bridges N
Am J Transplant. 2020; 21(4):1503-1512.
PMID: 32956576
PMC: 8048676.
DOI: 10.1111/ajt.16311.
Avoidance of CNI and steroids using belatacept-Results of the Clinical Trials in Organ Transplantation 16 trial.
Mannon R, Armstrong B, Stock P, Mehta A, Farris A, Watson N
Am J Transplant. 2020; 20(12):3599-3608.
PMID: 32558199
PMC: 7710570.
DOI: 10.1111/ajt.16152.
An age-independent gene signature for monitoring acute rejection in kidney transplantation.
Shaw B, Cheng D, Acharya C, Ettenger R, Lyerly H, Cheng Q
Theranostics. 2020; 10(15):6977-6986.
PMID: 32550916
PMC: 7295062.
DOI: 10.7150/thno.42110.
Daratumumab for Treatment of Antibody-Mediated Rejection after ABO-Incompatible Kidney Transplantation.
Spica D, Junker T, Dickenmann M, Schaub S, Steiger J, Rufli T
Case Rep Nephrol Dial. 2019; 9(3):149-157.
PMID: 31828078
PMC: 6902247.
DOI: 10.1159/000503951.
Prediction system for risk of allograft loss in patients receiving kidney transplants: international derivation and validation study.
Loupy A, Aubert O, Orandi B, Naesens M, Bouatou Y, Raynaud M
BMJ. 2019; 366:l4923.
PMID: 31530561
PMC: 6746192.
DOI: 10.1136/bmj.l4923.